-
公开(公告)号:GB1300166A
公开(公告)日:1972-12-20
申请号:GB1980270
申请日:1970-04-24
Applicant: BASF AG
Inventor: REIF WERNER , NUERRENBACH AXEL , FREYSCHLAG HERWIG
IPC: C07C403/00
Abstract: 1300166 Granular Vitamin A esters BADISCHE ANILIN- & SODA-FABRIK AG 24 April 1970 19802/70 Heading C2V Granular Vitamin A esters are prepared by dripping molten Vitamin A ester into an organic liquid at -10 to -70‹ C., the liquid being one in which the ester is insoluble and which has a lower density than the esters, the resultant granules then being separated and dried. The liquid may be an alcohol or a gasoline. An antioxidant may be added to the melt. In examples, molten Vitamin A acetate and Vitamin A palmitate are dripped into cooled methanol to form granules.
-
公开(公告)号:CA905980A
公开(公告)日:1972-07-25
申请号:CA905980D
Applicant: BASF AG
Inventor: GRASSNER HANS , NUERRENBACH AXEL , POMMER HORST , KLOTMANN GEORG
-
公开(公告)号:CA797871A
公开(公告)日:1968-10-29
申请号:CA797871D
Applicant: BASF AG
Inventor: REIF WERNER , FREYSCHLAG HERWIG , NUERRENBACH AXEL , POMMER HORST
-
公开(公告)号:GB1079216A
公开(公告)日:1967-08-16
申请号:GB4822664
申请日:1964-11-27
Applicant: BASF AG
Inventor: FREYSCHLAG HERWIG , REIF WERNER , NUERRENBACH AXEL , SARNECKI WILHELM
Abstract: The invention comprises ylenals, (i.e. compounds which in the same molecule contain a phosphorylene group and an aldehyde group in conjunction) of the formula where Ar is an aryl radical which may be substituted by alkyl or alkoxy groups; R1, R2 and R3 are H or alkyl groups and n is an integer from 1 to 6. They may be obtained by reacting a proton acceptor in liquid phase with a quaternary phosphonium salt of the formula where X(-) is a monovalent anion. Suitable proton acceptors are bases having a pK value below or about 9 such as alcoholates, ammonia, amines, e.g. alkylamines or heterocyclic amines, or aqueous alkali. Suitable solvents are water, dimethyl-formamide or sulphoxide, acetonitrile, alcohol, hydrocarbons, halogenated hydrocarbons or mixtures thereof. Specified products are triphenylphosphine-2-formylpropen-1-yl-1-methylene, triphenylphosphine-3-formylpropen-(2)-yl-2-methylene, triphenylphosphine-2 - methyl - 4 - formylbutadien - (1,3) - yl - 1 - methylene, triphenylphosphine-1-methyl-4-formylbutadiene - (1,3) - yl - 1 - methylene, and triphenylphosphine - 2,6 - dimethyl - 6 - formylhexatrien - (1,3,5) - yl - 1 - methylene. Examples are given for the preparation of triphenylphosphine - 2 - formylpropen - 1 - yl-methylene. The products are intermediates for the synthesis of dyes, pharmaceuticals, plant protection agents, food dyes and carolenoids. The phosphonium salts of Formula I may be obtained by reacting a suitable halogen compound with a triarylphosphine in an organic solvent.
-
公开(公告)号:FR1395458A
公开(公告)日:1965-04-09
申请号:FR975628
申请日:1964-05-23
Applicant: BASF AG
Inventor: NUERRENBACH AXEL , SARNECKI WILHELM , REIF WERNER
IPC: C07F9/54
-
公开(公告)号:FI88025C
公开(公告)日:1993-03-25
申请号:FI870356
申请日:1987-01-27
Applicant: BASF AG
Inventor: WUEST HANS-HEINER , JANSSEN BERND , FRICKEL FRITZ-FRIEDER , NUERRENBACH AXEL
IPC: A61K31/05 , A61K31/047 , A61K31/085 , A61K31/135 , A61K31/16 , A61K31/19 , A61K31/195 , A61K31/215 , A61K31/22 , A61K31/357 , A61K31/36 , A61P17/00 , A61P29/00 , A61P35/00 , C07C27/00 , C07C39/23 , C07C39/42 , C07C41/00 , C07C43/168 , C07C43/20 , C07C43/215 , C07C51/00 , C07C59/125 , C07C59/68 , C07C59/72 , C07C62/38 , C07C67/00 , C07C69/07 , C07C69/157 , C07C69/24 , C07C69/712 , C07C69/78 , C07C213/00 , C07C217/18 , C07D317/50 , C07D325/00 , C07C69/035 , C07C69/16
-
公开(公告)号:CA1266672A
公开(公告)日:1990-03-13
申请号:CA491249
申请日:1985-09-20
Applicant: BASF AG
Inventor: WUEST HANS-HEINER , FRICKEL FRITZ-FRIEDER , NUERRENBACH AXEL
IPC: C07D263/10 , A61K31/015 , A61K31/03 , A61K31/075 , A61K31/085 , A61K31/11 , A61K31/115 , A61K31/12 , A61K31/135 , A61K31/16 , A61K31/165 , A61K31/19 , A61K31/215 , A61K31/22 , A61K31/275 , A61K31/41 , A61P17/00 , A61P29/00 , A61P35/00 , C07C1/00 , C07C13/465 , C07C13/48 , C07C17/00 , C07C25/24 , C07C27/00 , C07C33/38 , C07C39/23 , C07C39/38 , C07C43/168 , C07C43/176 , C07C43/215 , C07C43/23 , C07C45/00 , C07C45/44 , C07C45/68 , C07C47/548 , C07C47/55 , C07C47/57 , C07C47/575 , C07C49/683 , C07C49/747 , C07C49/757 , C07C49/798 , C07C49/813 , C07C49/835 , C07C49/84 , C07C57/50 , C07C57/62 , C07C59/72 , C07C63/66 , C07C63/74 , C07C65/19 , C07C65/28 , C07C65/38 , C07C67/00 , C07C69/157 , C07C69/618 , C07C69/65 , C07C69/734 , C07C69/76 , C07C69/78 , C07C209/00 , C07C209/48 , C07C211/44 , C07C211/52 , C07C215/74 , C07C233/05 , C07C233/11 , C07C233/22 , C07C233/29 , C07C233/65 , C07C235/34 , C07C235/38 , C07C235/42 , C07C255/50 , C07C255/51 , C07C255/54 , C07C255/56 , C07D257/04 , C07C69/94 , C07C121/75
Abstract: Disclosed are novel diarylacetylene of the formula I: I where R1 and R2 are each hydrogen or methyl, R3 is hydrogen, methyl, hydroxyl or C1-C6-alkoxy, R4 is hydrogen, methyl or methoxy, R5 is hydrogen, halogen, methoxy or C1-C4-alkyl, A is a methylene or ethylene radical which is unsubstituted or substituted by C1-C4-alkyl or is -CH=CH-, -CHOH-CH2- or -CO-CH2-, and R is hydrogen, methyl, nitrile, tetrazolyl, C2-C10-ketal or a radical -CHR7-OR8, -CHR7-NR9R10, -COR11, -CR12=CH-COOR13 or -CR12=CH-CO-NR14R15, where R7 is hydrogen or C1-C4-alkyl, R8 is hydrogen, C1-C4-alkyl, C1-C20-alkanoyl, unsubstituted or substituted benzoyl or a radical -P(0) (OR13)2 or -P(0) (NR14R15)2 (where R13 is hydrogen, unsubstituted or hydroxyl-substituted C1-C8-alkyl, unsubstituted or substituted aryl, or aralkyl which is unsubstituted or substituted in the aryl moiety, and R14 and R15 are each hydrogen, unsubstituted or hydroxyl-substituted C1-C6-alkyl, or an unsubstituted or substituted aralkyl or aryl group), R9 and R10 are each hydrogen, C1-C4-alkyl, C1C6-unsubstituted or substituted benzoyl, R11 is hydrogen, halogen, C1-C4-alkyl or a radical NR14R15 or -OR13 (where R13, R14 and R15 have the above meanings) and R12 is hydrogen or methyl, and, where relevant, its physiologically tolerated salts. These derivatives are useful for the treatment of dermatological disorders and the prophylactic and therapeutic treatment of precanceroses and tumors.
-
公开(公告)号:AU578739B2
公开(公告)日:1988-11-03
申请号:AU4783485
申请日:1985-09-24
Applicant: BASF AG
Inventor: FRICKEL FRITZ FRIEDER , NUERRENBACH AXEL , THYES MARCO
IPC: A61K31/41 , A61P17/00 , A61P29/00 , A61P35/00 , C07D20060101 , C07D257/04
-
公开(公告)号:HUT43985A
公开(公告)日:1988-01-28
申请号:HU24387
申请日:1987-01-27
Applicant: BASF AG
Inventor: WUEST HANS-HEINER , JANSSEN BERND , FRICKEL FRITZ-FRIEDER , NUERRENBACH AXEL
IPC: A61K31/05 , A61K31/047 , A61K31/085 , A61K31/135 , A61K31/16 , A61K31/19 , A61K31/195 , A61K31/215 , A61K31/22 , A61K31/357 , A61K31/36 , A61P17/00 , A61P29/00 , A61P35/00 , C07C27/00 , C07C39/23 , C07C39/42 , C07C41/00 , C07C43/168 , C07C43/20 , C07C43/215 , C07C51/00 , C07C59/125 , C07C59/68 , C07C59/72 , C07C62/38 , C07C67/00 , C07C69/07 , C07C69/157 , C07C69/24 , C07C69/712 , C07C69/78 , C07C213/00 , C07C217/18 , C07D317/50 , C07D325/00
-
公开(公告)号:HU193818B
公开(公告)日:1987-12-28
申请号:HU355185
申请日:1985-09-20
Applicant: BASF AG
Inventor: WUEST HANS-HEINER , FRICKEL FRITZ-FRIEDER , NUERRENBACH AXEL
IPC: C07F9/09 , A61K20060101 , A61K31/66 , A61P17/00 , A61P29/00 , A61P35/00 , C07F20060101 , C07F9/11 , C07F9/12 , C07F9/24 , C07F9/59 , C07F9/6533 , C07F9/6574 , C07F9/6584
Abstract: A vinylbenzyl phosphate of the formula I where A, R1, R2, R3, R4, R5, R6, R7, R8 and R9 have the meanings stated in the description, and their preparation are described. The substances are useful for the treatment of disorders.
-
-
-
-
-
-
-
-
-